---
id: "entity-nmpa"
type: "entity"
entityType: "organization"
canonicalName: "National Medical Products Administration (NMPA)"
aliases: ["NMPA", "National Medical Products Association"]
source_timestamps: ["§ The Rise of Chinese Competition", "¶7"]
tags: ["regulatory-body", "china"]
related: ["concept-china-pharma-ascendance"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# National Medical Products Administration (NMPA)

China's national drug regulator — **functionally analogous to the U.S. FDA**. **Large-scale reforms to the NMPA** have been a critical catalyst creating the conditions for China's rapid ascent in pharmaceutical R&D (see [[concept-china-pharma-ascendance]]).

**Naming note:** the extraction rendered the name as "National Medical Products *Association*"; the canonical name is **National Medical Products *Administration***, retained here for cross-vault deduplication with the former as an alias.